Related Experiment Video
Updated: Jul 1, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Variant profile of Brazilian patients with Sanfilippo syndrome type B
Alice Brinckmann Oliveira Netto1, Ana Carolina Brusius-Facchin2, Kristiane Michelin-Tirelli3
1Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil.
Abstract:
Mucopolysaccharidosis type IIIB (MPS IIIB, or Sanfilippo syndrome type B) is a lysosomal storage disorder caused by variants in the NAGLU gene, leading to heparan sulfate accumulation. This study analyzed 27 MPS IIIB Brazilian patients diagnosed via the MPS Brazil Network (2014-2022). Diagnosis involved biochemical tests [NAGLU enzyme activity, urinary glycosaminoglycans (GAG)], showing expected low activity of the enzyme and high concentration of GAGs. Molecular analysis of the NAGLU gene by Sanger sequencing or Targeted Next-Generation Sequencing confirmed the diagnosis. Forty-nine variants were found across patient alleles, comprising twenty-two different variants. Two variants were described for the first time: p.Gly79Arg and p.Leu598Pro (both missense). In silico tools predicted the novel variants as damaging/deleterious. The study identified 90.7% of the expected mutant alleles, observing variant heterogeneity and a higher frequency of missense variants. This characterization enhances understanding of the Brazilian MPS IIIB genetic landscape and is instrumental to the design of diagnostic and screening strategies.
Insights
Mucopolysaccharidosis type IIIB (MPS IIIB) is a genetic disorder. Researchers identified new gene variants in Brazilian patients, improving understanding and diagnostic strategies for this rare disease.
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- Mucopolysaccharidosis type IIIB (MPS IIIB) is a lysosomal storage disorder.
- It results from variants in the NAGLU gene, causing heparan sulfate accumulation.
- MPS IIIB is also known as Sanfilippo syndrome type B.
Purpose of the Study:
- To characterize the genetic landscape of MPS IIIB in Brazilian patients.
- To identify novel NAGLU gene variants.
- To inform diagnostic and screening strategies for MPS IIIB in Brazil.
Main Methods:
- Biochemical tests including NAGLU enzyme activity and urinary glycosaminoglycans (GAG) analysis.
- Molecular analysis of the NAGLU gene using Sanger sequencing or Targeted Next-Generation Sequencing.
- In silico prediction of pathogenicity for novel variants.
Main Results:
- Analysis of 27 Brazilian MPS IIIB patients (2014-2022).
- Identified 49 variants across patient alleles, including 22 distinct variants.
- Discovered two novel missense variants (p.Gly79Arg and p.Leu598Pro), predicted as deleterious.
- Detected 90.7% of expected mutant alleles, showing variant heterogeneity and a high frequency of missense variants.
Conclusions:
- The study provides a comprehensive characterization of the Brazilian MPS IIIB genetic spectrum.
- Novel variants were identified, expanding the known mutational landscape.
- Findings are crucial for developing targeted diagnostic and screening approaches for MPS IIIB.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pedigree Analysis
Pleiotropy
Huntington Disease l: Introduction
Sex-linked Disorders
Leishmaniasis
